Revenue Cycle AI is Costly and Cumbersome - Here’s Why Leaders are Still Buying In

Revenue cycle leaders are finding that the technology, which expands on automation with generative and predictive capabilities, has been good so far at reducing and improving administrative tasks. ROI is fleeting, and the true test of AI will come when it’s used to improve payer relations and patient financial engagement.

The 2024 HealthLeaders AI in Finance and Revenue Cycle Mastermind program brought together revenue cycle leaders who are advancing AI in their health systems. Through virtual meetings and an in-person roundtable, the participating executives combined their knowledge and experience to provide a framework from which other health systems might chart their RCM path in the future.

In this robust report, we will examine how prominent revenue cycle leaders who stand on the brink of advancing AI find themselves caught between the enormous potential for efficiency and cost savings and the perilous task of navigating a labyrinth of challenges.

Read the report to learn more!